Decoy Therapeutics IncDCOY
Price$1.85

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
1analyst covering
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Lead Candidate Selection QuarterlyTarget: Nomination of clinical candidate
Computational Peptide Design Capacity Annually1.0Target: 25x to 100x increase
Watch Items
  • Phase 1 Clinical Trial Initiation for DCOY-COVTrigger: Filing of Clinical Trial Application (CTA) in EEAAction: Triggers potential Series A milestone warrant exercise of $3.5 million
  • Phase 2a Human Challenge Trial Approval in the UKTrigger: Formal written approval from the MHRAAction: Triggers potential Series B milestone warrant exercise of $7.0 million
  • Phase 2a Human Challenge Trial Data AnnouncementTrigger: Public announcement of positive Phase 2a dataAction: Triggers potential Series C milestone warrant exercise of $7.0 million
Sign in / Sign up to read more

Research as of 24 Jul 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.